Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.
Reads0
Chats0
TLDR
The depth of invasion was studied using the criteria for staging of Clark et al.2 to see if maximal cross-sectional area, thickness, stage of invasion, or a combination of these can be of value in assessing the prognosis of cutaneous melanoma.Abstract:
CuTANEous melanoma is a most unpredictable lesion. The marked variation in prognosis is probably a function of many variables, one of which is the size of the tumor. Though there is a roughly inverse relationship between the diameter of the lesion and survival,5 very small lesions have recurred or metastasized. One possible reason for the lack of reliability of tumor size in estimating prognosis may be that studies to date have considered size in only two diamensions and have neglected tumor volume. Two melanomas can have the same diameter but differ greatly in thickness because of variation in either depth of invasion or degree of protrusion from the surface of the skin or both. A recent study 2 has shown that prognosis correlates well with staging of the depth of invasion, but there have been no studies relating survival to tumor volume. To measure tumor volume it is necessary to know the surface area of the tumor, but in this retrospective study we only know the maximal diameters of the lesions. By measuring the maximal thickness of the lesions we can calculate the maximal crosssectional area, which should be roughly proportional to the volume of the tumor. The depth of invasion was also studied using the criteria for staging of Clark et al.2 to see if maximal cross-sectional area, thickness, stage of invasion, or a combination of these can be of value in assessing the prognosis of cutaneous melanoma. A total of 98 lesions were so studied.read more
Citations
More filters
Journal ArticleDOI
BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival
Lars A. Akslen,Sabrina Angelini,Oddbjørn Straume,Ingeborg M. Bachmann,Anders Molven,Kari Hemminki,Kari Hemminki,Rajesh Kumar,Rajesh Kumar +8 more
TL;DR: In this article, the authors examined the relationship between mutations in the BRAF and NRAS genes and tumor cell proliferation in cutaneous melanoma, and found that mutations in BRAF were mutually exclusive in all but one case, and were maintained from primary tumors through their metastases.
Journal ArticleDOI
Involvement of E‐cadherin, β‐catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma
M. G. Tucci,Guendalina Lucarini,Donatella Brancorsini,Antonio Zizzi,Armanda Pugnaloni,A. Giacchetti,G. Ricotti,Graziella Biagini +7 more
TL;DR: The development of melanoma may be viewed as a consequence of the disruption of homeostatic mechanisms in the skin of the original site as well as the migration of tumour cells from their original location to a secondary site.
Journal ArticleDOI
The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients.
TL;DR: The prognostic value of the TNM classifications of the UICC dated 1978 and 1987, was investigated in a population of 2,495 patients who were followed up over the long term, and grading cutoffs at 1, 2 and 4 millimetres proved to be particularly favourable for a classification in accordance with prognostic criteria.
Journal ArticleDOI
Experience of a public education programme on early detection of cutaneous malignant melanoma.
V. R. Doherty,R. M. MacKie +1 more
TL;DR: A public education campaign is described which aimed at encouraging earlier self recognition and thus treatment of cutaneous malignant melanoma and a statistically significant rise was seen in the percentage of thin melanomas with a good prognosis that were treated and a concomitant significant fall in the proportion of thick lesions with a poor prognosis.
Journal ArticleDOI
Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.
TL;DR: The loss of AP-2 expression seems to be associated with malignant transformation and tumor progression in cutaneous malignant melanoma, and this tumor-suppressive action ofAP-2 may be mediated through p21 regulation.
References
More filters
Journal ArticleDOI
Some Methods for Strengthening the Common χ 2 Tests
TL;DR: In this article, the authors discuss two kinds of failure to make the best use of x2 tests which I have observed from time to time in reading reports of biological research, and propose a number of methods for strengthening or supplementing the most common uses of the ordinary x2 test.
Journal Article
The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin
TL;DR: Evidence is presented suggesting that superficial spreading melanoma and lentigo maligna melanoma (Hutchinson9s melanotic freckle) show a long period of superficial growth, followed by the relatively rapid appearance of nodules or deeper invasion within the primary lesion.
Journal ArticleDOI
The Detection of Partial Association, I: The 2 × 2 Case
TL;DR: In this article, a criterion for testing null hypotheses of conditional independence of two dichotomous random variables is derived for testing whether the association of the two random variables in the conditional distribution is, in a certain sense, constant.
Journal ArticleDOI
Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults.
Related Papers (5)
The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Charles M. Balch,Antonio C. Buzaid,Seng Jaw Soong,Michael B. Atkins,Natale Cascinelli,Daniel G. Coit,Irvin D. Fleming,Jeffrey E. Gershenwald,Alan Houghton,John M. Kirkwood,Kelly M. McMasters,Martin F. Mihm,Donald L. Morton,Douglas S. Reintgen,M. I. Ross,Arthur J. Sober,John A. Thompson,John F. Thompson +17 more
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch,Jeffrey E. Gershenwald,Seng-Jaw Soong,John F. Thompson,Michael B. Atkins,David R. Byrd,Antonio C. Buzaid,Alistair J. Cochran,Daniel G. Coit,Shouluan Ding,Alexander M.M. Eggermont,Keith T. Flaherty,Phyllis A. Gimotty,John M. Kirkwood,Kelly M. McMasters,Martin C. Mihm,Donald L. Morton,Merrick I. Ross,Arthur J. Sober,Vernon K. Sondak +19 more
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Charles M. Balch,Seng Jaw Soong,Jeffrey E. Gershenwald,John F. Thompson,Douglas S. Reintgen,Natale Cascinelli,Marshall M. Urist,Kelly M. McMasters,M. I. Ross,John M. Kirkwood,Michael B. Atkins,John A. Thompson,Daniel G. Coit,David R. Byrd,Renee A. Desmond,Yuting Zhang,Ping-Yu Liu,Gary H. Lyman,Aberto Morabito +18 more